Author: Supriya Jena

  • Unimech Aerospace IPO: Shares Drop After Strong Debut

    Unimech Aerospace IPO: Shares Drop After Strong Debut

    Shares of Unimech Aerospace and Manufacturing dropped by 9.4%, reaching Rs 1,350.4 on the BSE after a bright start on Tuesday. The stock opened at Rs 1,491 on the BSE, which was a big gain of Rs 706 or 90% above the IPO price of Rs 785. On the NSE, it started at Rs 1,460.

    Unimech Aerospace raised Rs 500 crore through their IPO. This included a new issue of Rs 250 crore and an offer for sale of Rs 250 crore. The IPO was open for people to buy shares from December 23 to 26. It was very popular and got 175.31 times more bids than shares available, with 82.46 crore shares bid for against 47.04 lakh shares offered. Retail investors showed a lot of interest, subscribing 56.74 times. Meanwhile, non-institutional investors subscribed 263.78 times and qualified institutional buyers did even better at 317.63 times.

    Experts suggested that investors should buy into this IPO because the company is doing well in the aerospace industry by making important parts for airplane manufacturers. Canara Bank Securities even gave a ‘subscribe’ rating, saying Unimech Aerospace shows great potential for growth and has good value for its services.

    Unimech Aerospace and Manufacturing creates crucial components, such as tools for airplanes, support equipment, and parts for industries like aerospace, defense, energy, and semiconductors.

    Anand Rathi Securities and Equirus Capital were the main managers for the Unimech Aerospace IPO, while Kfin Technologies handled the registration.

    (Disclaimer: The opinions and recommendations of experts are their own and do not reflect the views of Niftystat.)

  • Varun Beverages: Poised for Growth with New Acquisitions

    Varun Beverages: Poised for Growth with New Acquisitions

    Domestically, Varun Beverages Limited (VBL), the biggest PepsiCo bottler in India, is expected to do really well! Antique Broking, a local brokerage firm, thinks the company’s stock could reach Rs 710, which is about a 10% increase from where it is now.

    Antique Broking says that VBL will grow because it is entering new drink categories like energy drinks and dairy products. The company is also expanding its factories, which will help it produce more drinks and improve profits. They plan to sell more snacks too, which will help increase their earnings even more.

    Recently, VBL made some big moves by buying rights to sell PepsiCo products in Africa, specifically in Tanzania and Ghana. In Tanzania, the market for Pepsi products is huge, with about 200 million cases available. VBL purchased this for Rs 1,750 crore, with hopes of double-digit growth soon. In Ghana, the company earned rights to a smaller market of 20 million cases for Rs 190 crore. This gives VBL a chance to learn more about West Africa and grow its market share there.

    The company raised Rs 7,500 crore through a new share sale, which will help it pay for these acquisitions and even buy more stakes in Lunarmech Technologies. Because of these moves, VBL is becoming a “net cash company,” which means it will have more money on hand.

    VBL has been working with PepsiCo for over 32 years, covering many areas in India and other countries like Nepal, Sri Lanka, and various African nations.

    As of today, Varun Beverages shares were trading slightly lower at Rs 636.30 on the stock market.

  • Indian Oil Corp: Today’s Share Price Update and Insights”

    Indian Oil Corp: Today’s Share Price Update and Insights”

    Today, the shares of Indian Oil Corporation Ltd. dipped by 0.48%, trading at Rs 135.45 as of 11:27 AM (IST). The stock opened lower than yesterday’s close. So far, around 311,947 shares have changed hands, bringing in about Rs 4.21 crore.

    The stock’s earnings compared to its price (known as the price-to-earnings or P/E ratio) is 10.93, and it has a price-to-book value of 1.26. This means for every rupee of its value, investors are paying Rs 1.26. The company’s return on equity (ROE), which shows how well it uses its money to make profits, stands at 22.75%.

    During the day, the stock reached a high of Rs 135.95 and a low of Rs 134.30. Over the past year, the stock hit its highest price at Rs 196.80 and its lowest at Rs 128.50.

    When looking at volatility, which measures how much the stock price moves compared to the market, the stock has a beta value of 1.4017.

    Technical Indicators:
    The stock’s 200-day moving average (200-DMA) is Rs 162.08, while the 50-day moving average (50-DMA) is Rs 141.28. If a stock price is above both levels, it usually means it’s on an upward trend. If it’s below, the trend is bearish. Currently, it’s trading between these two averages, suggesting it could move in either direction.

    The Relative Strength Index (RSI) of this stock is 39.63, signaling that it is nearing an oversold condition. An RSI above 70 indicates a stock might be overbought, while below 30 suggests it might be oversold.

    Promoter Holding: As of September 30, 2024, the promoters own 51.5% of the company’s shares. Overseas investors hold 7.9%, and domestic institutional investors have 10.37%.

  • Nifty Pharma Index Update: Who’s Winning and Losing Today?”

    Nifty Pharma Index Update: Who’s Winning and Losing Today?”

    On Tuesday morning at 11:06 AM (IST), the Nifty Pharma index was showing mixed results in a weak overall market. Some companies, like Aurobindo Pharma (up 2.44%), Lupin (up 2.33%), Zydus Lifesciences (up 1.41%), Divi’s Laboratories (up 1.13%), and Sun Pharmaceutical (up 1.07%), were doing well.

    On the other hand, Biocon (down 1.38%), Gland Pharma (down 1.09%), Ajanta Pharma (down 0.74%), and Torrent Pharmaceuticals (down 0.46%) were facing losses. At that time, the Nifty Pharma index was at 23,439.05, showing an increase of 0.85%.

    Overall, the benchmark NSE Nifty50 index fell by 88.56 points to 23,556.35, while the BSE Sensex dropped by 351.26 points to 77,896.87. Out of 50 stocks in the Nifty index, 21 were gaining, while 29 were losing.

    Some of the most traded shares included Vodafone Idea, ITI Ltd., IRFC, YES Bank, and Rites. Several stocks reached fresh 52-week highs, like Asian Hotels, Atlas Cycles, Indo Thai Sec, Lupin, and Aarvee Denims, while others, including Barak Valley, Arshiya, Mamata Machinery, Universus Photo, and Suraksha Diagnostic, hit new 52-week lows.

  • Biden Criticized for Comments After Jimmy Carter’s Death

    Biden Criticized for Comments After Jimmy Carter’s Death

    President Joe Biden faced backlash from conservative critics after he made comments about former President Jimmy Carter’s passing. When asked what Donald Trump could learn from Carter, Biden said, “Decency, decency, decency.” He explained that Carter was a good person who wouldn’t ignore someone in need or judge others by their appearance or speech.

    Many people were upset, feeling Biden should have simply honored Carter instead of taking a shot at Trump. Radio host Jorge Bonilla commented that it was wrong for Biden to lecture others on decency, calling it “unmitigated gall.” Hugh Hewitt, another commentator, questioned if it was truly decent for Biden to have hidden information about his health, accusing the media of covering it up.

    Legal expert Jonathan Turley pointed out that while Carter did not pardon his brother involved in a scandal, Biden pardoned his son Hunter after saying he wouldn’t. Carter, who passed away at 100 years old on December 29, was remembered by Trump as a president who faced big challenges and worked hard to help people. Trump praised him on social media, saying they all owe him gratitude for his efforts.

  • Divi’s Laboratories Shares Rise: Key Financial Insights and Trends

    Divi’s Laboratories Shares Rise: Key Financial Insights and Trends

    On Tuesday, shares of Divi’s Laboratories Ltd. increased by 0.49%, reaching a price of Rs 6089.70 as of 10:50 AM (IST). During trading, the stock hit a high of Rs 6100.00 and a low of Rs 5978.70.

    The company’s Return on Equity (ROE), which measures how well it uses investors’ money, is 11.78%. By 10:50 AM, about 10,000 shares had been traded, with a total turnover of Rs 2.24 crore.

    In the past year, Divi’s Laboratories has seen its stock price fluctuate significantly, with a highest price of Rs 6448.75 and a lowest price of Rs 3350.05. The stock’s Beta value is 1.0009, indicating it moves about as much as the overall market.

    Who Owns Divi’s Laboratories?
    As of September 30, 2024, the company’s major stakeholders include:
    – Promoters: 51.89%
    – Foreign Investors: 17.25%
    – Domestic Institutional Investors: 11.92%

    Financial Highlights
    For the quarter ending September 30, 2024, Divi’s Laboratories reported consolidated sales of Rs 2444.00 crore, showing a growth of 11.24% from the previous quarter and 22.51% from the same quarter last year. The net profit after tax for this latest quarter was Rs 510.0 crore, up 46.55% compared to a year ago.

    Technical Signals
    The MACD (Moving Average Convergence Divergence) is giving a positive signal for the stock. This tool helps traders see potential trend changes, showing buy or sell opportunities based on price movements.

  • Indian Market Set to Drop: Key Insights and Stock Picks

    Indian Market Set to Drop: Key Insights and Stock Picks

    On Tuesday, the Indian stock market is expected to drop because of weak signals from global markets. On Monday, the Nifty futures closed down by 0.73%, hitting 23,816.

    Looking at options data, most traders are focusing on the 25,000 mark for call options and 22,500 for put options. Some significant call options are being written at the 24,000 and 23,800 levels, while put writing is seen at 23,200 and 23,000 levels.

    Experts say the market will likely stay between 23,200 and 24,200, with a more immediate range of 23,500 to 23,900. Chandan Taparia, an expert from MOFSL, indicated that the Nifty created a bearish pattern on the daily chart, meaning it might likely go down further. As long as it stays below 23,800, it could drop to 23,500 or even 23,350. Resistance is at 23,750 and 23,900.

    Here are some stock recommendations for short-term traders:

    Ajit Mishra, SVP – Technical Research, Religare Broking Ltd
    – Glenmark Pharma: Buy | Target: Rs 1,690 | Stop Loss: Rs 1,545
    – Laurus Labs: Buy | Target: Rs 640 | Stop Loss: Rs 572
    – Hindalco: Sell | Target: Rs 572 | Stop Loss: Rs 622
    – Tata Power: Sell | Target: Rs 364 | Stop Loss: Rs 405

    Nooresh Merani, Independent Technical Analyst
    – Sun Pharma: Buy | Target: Rs 1,950 | Stop Loss: Rs 1,850
    – Apollo Hospitals: Buy | Target: Rs 7,700 | Stop Loss: Rs 7,200
    – Muthoot Finance: Buy | Target: Rs 2,250 | Stop Loss: Rs 2,050

    (Disclaimer: The suggestions mentioned here are based on expert opinions and do not reflect the views of NiftyStat.)

  • RVNL Secures ₹137.16 Crore Project: Share Insights and Updates

    RVNL Secures ₹137.16 Crore Project: Share Insights and Updates

    Shares of Rail Vikas Nigam Limited, or RVNL, are getting a lot of attention today. The company announced that they won a big bidding opportunity for a project worth ₹137.16 crore. This project is for building and maintaining a traction substation along the Bhusaval-Khandwa railway sections.

    According to RVNL, they are the lowest bidder, which means they offered the cheapest price for this work. They will be in charge of designing, supplying, setting up, testing, and making sure everything works perfectly for the railway. RVNL is expected to finish this project in about 12 months.

    In the past year, RVNL shares have jumped by 125%, but over the last six months, they have dropped by about 23%. The stock was recently priced at ₹409.10. Currently, its position is not very strong, as it is below several important moving averages, and its relative strength indicator (RSI) is around 32, which is a mid-range level.

    In summary:
    – RVNL is working on a big railway project.
    – Shares have had a great year but fell in the last 6 months.
    – The project will take about 12 months to complete.

  • India’s Cricket Journey: 2024 Challenges and 2025 Schedule Ahead

    India’s Cricket Journey: 2024 Challenges and 2025 Schedule Ahead

    The Indian men’s cricket team had a year full of ups and downs in 2024, and we’re hoping for better things in 2025! Next year, India will play in big tournaments like the Champions Trophy, five Tests against England, and the Asia Cup.

    Unfortunately, 2024 ended heartbreakingly for India as they lost to Australia by 184 runs in their final match at the famous Melbourne Cricket Ground. Since winning the T20 World Cup in the Caribbean, India hasn’t been able to get the results they wanted. They faced tough losses, like losing an ODI series to Sri Lanka and a home Test series to New Zealand.

    Overall, in 2024, India played 15 Test matches, winning 8, losing 6, and drawing 1. They only had one ODI series, and they lost that to Sri Lanka in three matches.

    As 2025 begins, India will face Australia in the last Test of the Border-Gavaskar Trophy at the Sydney Cricket Ground. This match is very important because India needs to win to have a chance to play in the World Test Championship final. If they lose or draw, they’ll be out.

    After the Sydney Test, India’s focus will shift to the Champions Trophy in February, where they’ll play their first match against Bangladesh in Dubai on February 20.

    Here’s what India’s cricket schedule looks like for 2025:

    – India vs Australia: 5th Border-Gavaskar Trophy Test in Sydney
    – India vs England: 5 T20Is and 3 ODIs from January 22
    – 1st T20I: January 22 (Chennai)
    – 2nd T20I: January 25 (Kolkata)
    – 3rd T20I: January 28 (Rajkot)
    – 4th T20I: January 31 (Pune)
    – 5th T20I: February 2 (Mumbai)
    – 1st ODI: February 6 (Nagpur)
    – 2nd ODI: February 9 (Cuttack)
    – 3rd ODI: February 12 (Ahmedabad)

    – Champions Trophy: February-March 2025
    – India vs Bangladesh: February 20 (Dubai)
    – India vs Pakistan: February 23 (Dubai)
    – India vs New Zealand: March 2 (Dubai)
    – Semi-final (if qualified): March 4 (Dubai)
    – Final (if qualified): March 9 (Dubai)

    – World Test Championship final (if qualified) – June 2025 (Lord’s Cricket Ground)

    – India vs England: 5 Tests from June to August
    – 1st Test: June 20-24 (Headingley)
    – 2nd Test: July 2-6 (Edgbaston)
    – 3rd Test: July 10-14 (Lord’s)
    – 4th Test: July 23-27 (Manchester)
    – 5th Test: July 31-August 4 (Oval)

    – India vs Bangladesh: 3 ODIs and 3 T20Is in August

    – India vs West Indies: 2 Tests in October

    – Asia Cup T20s: October-November

    – India vs Australia: 3 ODIs and 5 T20Is in November

    – India vs South Africa: 2 Tests, 3 ODIs, and 5 T20Is in November-December

  • Gold Prices Steady as 2023 Ends with Strong Performance

    Gold Prices Steady as 2023 Ends with Strong Performance

    Gold prices stayed the same during the early hours of Tuesday, marking the last trading day of a busy year. This year, gold had its best performance in over ten years!

    What’s Happening?
    – Spot gold remains at $2,606.07 per ounce, while U.S. gold futures went up by 0.1%, reaching $2,619.90.
    – Trading is expected to be slow today since it’s the last day of the year.

    Why Did Gold Do Well This Year?
    Gold saw a lot of buying from central banks, easier money policies, and tensions around the world. This drove gold prices to record highs, making it the best year for gold since 2010 with a jump of over 26%!

    What Might Affect Gold Prices Next Year?
    – The U.S. Federal Reserve has adjusted their predictions. They now expect to lower interest rates by 50 basis points in 2025, down from 100.
    – Fed Chair Jerome Powell said they will consider more rate cuts if inflation decreases.
    – Usually, people buy gold to protect against inflation and uncertainty, but higher interest rates can make gold less attractive.

    Looking Ahead
    Investors are waiting for new developments that could affect gold prices. Several important U.S. economic reports will be released next week, including job openings, the ADP employment report, and the U.S. employment report.

    China’s Gold Buying
    In more news, China’s gold imports from Hong Kong more than doubled in November compared to October, reaching the highest level seen in seven months!

    Other Precious Metals
    – Silver is stable at $28.94 per ounce.
    – Palladium is up by 0.1% to $901.49.
    – Platinum dropped by 0.4% to $900.00.
    Silver is on track for its best year since 2020, but platinum and palladium are expected to end the year with losses.

    Upcoming Data
    The next big update is the China Manufacturing PMI set for 1:30 AM GMT